Page 11 - தேசிய ஆரோக்கியம் ஒழுங்குமுறை அதிகாரம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Daily Tribune – www.newsofbahrain.com The National Health Regulatory Authority (NHRA) has approved Sotrovimab for emergency use, a new drug by GlaxoSmithKline (GSK) for the treatment of COVID-19. The decision to add Sotrovimab to COVID-19 treatment protocols follows emergency use approval by the US Food and Drug Administration (FDA) as well as a comprehensive review of GSK’s clinical trials. Sotrovimab-VIR-7831 develops “monoclonal antibodies” and will be used to treat infected adults and adolescents with mild to moderate COVID-19 symptoms who are at risk of their condition deteriorating and resulting in hospitalisation. Safety and efficacy evidence demonstrates a reduction in the number of cases requiring hospitalisation for more than 24 hours and a reduction in the number of fatalities by 85% when administered at an early stage of treatment.

Astrazeneca covishieldNational health regulatory authorityDrug administrationDaily tribuneBahrain authorises covid 19 drug sotrovimab for emergency useதேசிய ஆரோக்கியம் ஒழுங்குமுறை அதிகாரம்தினசரி ட்ரிப்யூன்